Primary Intestinal Lymphangiectasia (Waldmann's Disease): A Patient Guide
At a Glance
Primary intestinal lymphangiectasia (Waldmann's disease) causes leaky intestinal lymph vessels and protein loss. Care usually centers on a specialist-supervised low-fat diet with medium-chain triglyceride oil, plus ongoing checks of nutrition, bones, and immune health.
Primary intestinal lymphangiectasia (PIL), also known as Waldmann’s disease, is an exceptionally rare condition where the tiny drainage pipes in the small intestine—the lymphatics—are malformed from birth [1]. These vessels normally transport a nutrient-rich, milky fluid called chyle, which contains fats, proteins, and essential immune cells. In PIL, these malformed vessels become swollen and leaky, dumping this precious fluid directly into the digestive tract instead of returning it to the bloodstream [2][3].
Please note: This guide is educational. Diet, supplements, genetic testing, and medical decisions must be individualized with your specialist team.
This constant leak results in a condition called protein-losing enteropathy (PLE), which can have profound effects on the entire body. When you lose these proteins and cells, you may experience significant swelling (edema) in your limbs, persistent fatigue, and a weakened immune system that is less able to fight off infections [1][4]. Because the body also loses its ability to absorb certain fats and vitamins, nutritional deficiencies—particularly those affecting bone health and growth—can become a central concern [5].
Living with PIL requires a dedicated and specialized approach to care. Because the condition is so rare, it is essential to work with a medical team that has experience in rare lymphatic and gastrointestinal disorders to ensure an accurate diagnosis. A critical part of this process is ruling out “secondary” causes, such as heart or liver conditions, which can mimic the symptoms of PIL but require entirely different treatments [6][7]. Confirming that the condition is “primary” allows your team to focus on the specialized therapies that target the lymphatic vessels themselves.
The foundation of managing PIL is usually a long-term nutritional strategy that reduces lymph flow and protein loss. By following a low-fat diet that limits long-chain triglycerides (LCTs), you can physically reduce the pressure and flow within the intestinal lymphatics, effectively “plugging” the leak from the inside [8][9]. To ensure you still get the energy you need, this is typically paired with medium-chain triglyceride (MCT) oil, a type of fat that bypasses the broken lymphatic system entirely [10]. While this dietary shift is significant, it is a powerful tool that helps many patients regain their energy and stabilize their health for the long term [11]. Some patients can cautiously liberalize it later under supervision.
Beyond diet, staying healthy with PIL involves consistent, lifelong monitoring. Because the disease affects the body’s baseline levels of proteins, minerals, and immune cells, regular blood work and check-ups are necessary to protect your bone density and manage your infection risk [1][5]. While the journey with a rare diagnosis can feel overwhelming, understanding the biology of the leak and working closely with a knowledgeable team provides a clear path forward for maintaining a high quality of life.
In this guide
7 chapters
The Biology of Lymphatic Leakage and Diagnosis
Learn how primary intestinal lymphangiectasia causes protein loss and how stool tests, endoscopy, biopsies, and scans distinguish primary from secondary disease.
Recognizing Symptoms and Emergency Red Flags
Learn the common symptoms of primary intestinal lymphangiectasia, including swelling and diarrhea, and when breathing trouble, clots, or fever require urgent care.
Genetic Causes and Syndromic Associations
Learn how genetic causes of primary intestinal lymphangiectasia, including CHAPLE and Hennekam syndromes, affect testing, treatment, family care, and monitoring.
Dietary Therapy and Nutritional Management
Learn how primary intestinal lymphangiectasia diet therapy uses low-fat foods, MCT oil, protein, vitamins, and lab checks to support nutrition and manage symptoms.
Advanced Medical and Surgical Interventions
Learn about advanced treatment for primary intestinal lymphangiectasia, including octreotide, sirolimus, embolization, surgery, TPN, and supportive care.
Building Your Care Team and Preparing for Consultations
Learn how to build a Primary Intestinal Lymphangiectasia care team, prepare for specialist visits, gather records, and plan long-term monitoring for PIL.
Long-Term Monitoring and Survivorship
Learn how primary intestinal lymphangiectasia monitoring protects bone and immune health, guides lab tests, and shows when imaging or endoscopy may be needed.
Common questions in this guide
What is primary intestinal lymphangiectasia, also called Waldmann's disease?
How do doctors determine whether intestinal lymphangiectasia is primary?
What diet is usually recommended for Waldmann's disease?
What monitoring does primary intestinal lymphangiectasia require?
Which specialists may be involved in treating PIL?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Primary intestinal lymphangiectasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific tests were used to confirm that my lymphangiectasia is primary rather than secondary to a heart or liver condition?
- 2.How will we coordinate my care between a gastroenterologist, a specialized dietitian, and potentially an immunologist?
- 3.What is our individualized plan for monitoring my bone density, nutritional status, and immune cell counts?
- 4.Are there specialized lymphatic imaging centers you recommend if my symptoms do not respond to the standard diet?
References
References (11)
- 1
Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).
Vignes S, Uzzan M, Arrivé L, et al.
Orphanet journal of rare diseases 2025; (20(1)):356 doi:10.1186/s13023-025-03657-9.
PMID: 40640921 - 2
CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease.
Ozen A
Immunological reviews 2019; (287(1)):20-32 doi:10.1111/imr.12715.
PMID: 30565236 - 3
An unusual etiology of diarrhea: primary intestinal lymphangiectasia.
Dai C, Huang YH
Revista espanola de enfermedades digestivas 2026; (118(2)):118-119 doi:10.17235/reed.2025.11483/2025.
PMID: 40737280 - 4
Primary intestinal lymphangiectasia in children: Twelve years of experience in the diagnosis and management.
Niu Y, Wu Q, Wang Y, et al.
Asia Pacific journal of clinical nutrition 2021; (30(3)):358-364 doi:10.6133/apjcn.202109_30(3).0002.
PMID: 34587695 - 5
Secondary Hyperparathyroidism in Primary Intestinal Lymphangiectasia: A Report of Four Cases.
Zhang DX, Hao K, Zhang L, et al.
Gastroenterology research 2025; (18(3)):152-158 doi:10.14740/gr2022.
PMID: 40503188 - 6
Waldmann's disease: a rare cause of protein losing enteropathy in an adult patient.
Martins CR, Gagnaire A, Rostain F, Lepage C
Revista espanola de enfermedades digestivas 2017; (109(5)):385-388 doi:10.17235/reed.2017.4593/2016.
PMID: 28376626 - 7
Waldmann's Disease (Primary Intestinal Lymphangiectasia) with Atrial Septal Defect.
Aroor S, Mundkur S, Kanaparthi S, Kumar S
Journal of clinical and diagnostic research : JCDR 2017; (11(4)):SD03-SD04 doi:10.7860/JCDR/2017/24989.9742.
PMID: 28571224 - 8
Intestinal lymphangiectasia: Understanding the bigger picture.
Marrapu S, Kumar R
World journal of clinical cases 2024; (12(18)):3298-3303 doi:10.12998/wjcc.v12.i18.3298.
PMID: 38983414 - 9
Primary intestinal lymphangiectasia presenting as limb hemihyperplasia: a case report and literature review.
Khayat AA
BMC gastroenterology 2021; (21(1)):225 doi:10.1186/s12876-021-01813-6.
PMID: 34006223 - 10
Comprehensive nutrition guidelines and management strategies for enteropathy in children.
Savoca ML, Brownell JN
Seminars in pediatric surgery 2024; (33(3)):151425 doi:10.1016/j.sempedsurg.2024.151425.
PMID: 38849288 - 11
Clinical presentation, treatment, and outcome of children with primary intestinal lymphangiectasia: A national retrospective study.
Goret N, Lambe C, Ecochard-Dugelay E, et al.
Journal of pediatric gastroenterology and nutrition 2026; (82(2)):398-406 doi:10.1002/jpn3.70266.
PMID: 41277165
This guide explains primary intestinal lymphangiectasia, its nutritional treatment, and monitoring needs for informational purposes only and does not constitute medical advice. Your specialist team and dietitian should individualize diet, supplements, testing, and treatment.